by American Society of Clinical Oncology (ASCO)
JCO Precision Oncology Conversations podcasts features discussions with leading authors of JCO Precision Oncology articles, hosted by Dr. Abdul Rafeh Naqash. Join our experts in engaging conversations as they examine groundbreaking research in the world of precision oncology and learn how these advancements are redefining treatment protocols. The year's fellows summarize the top JCO Precision Oncology articles in the series, JCO PO Article Insights.
Language
🇺🇲
Publishing Since
9/21/2022
See how your podcast performs across key metrics
Recommendations available
Unlock the full report to see detailed tips
Recommendations available
Unlock the full report to see detailed tips
Unlock comprehensive insights including:
See how your show performs across every key metric
High authority scores make your podcast more attractive to industry leaders and influencers who want to appear on credible shows.
Sponsors look for podcasts with proven authority and engagement. Your score demonstrates your podcast's value to potential partners.
Understanding your strengths and weaknesses helps you make data-driven decisions to expand your listener base effectively.
Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.
May 27, 2026
<p>In this JCO PO Article Insights episode, host Jordan Goldstein summarizes the article, "<a href= "../../../doi/full/10.1200/PO-25-01229">EXONERATE-TRaCE: A Liquid Biopsy for Tracking Response to Anti–Epidermal Growth Factor Receptor–Based Therapy in Metastatic Colorectal Cancer</a>" byTakahashi, et al.</p> <p><a href= "https://ascopubs.org/do/jco-po-article-insights-longitudinal-monitoring-anti-egfr-based-therapy-crc"> <strong>LINK TO FULL TRANSCRIPT</strong></a></p>
May 20, 2026
<p>JCO PO author Dr. Tejas Patil at University of Colorado Cancer Center shares insights into the JCO PO article, "<a href= "https://ascopubs.org/doi/pdf/10.1200/PO-25-00221" target="_blank" rel="noopener">CRESTONE: A Phase II Study of the Efficacy and Safety of the HER3 Monoclonal Antibody, Seribantumab, in Solid Tumors With Neuregulin-1 (NRG1) Fusions</a>". Host Dr. Rafeh Naqash and Dr. Patil discuss the anti-tumor activity and safety data of seribantumab from the CRESTONE study (NCT04383210).</p> <p><a href= "https://ascopubs.org/do/phase-ii-study-seribantumab-tumors-harboring-nrg1-fusions" target="_blank" rel="noopener">LINK TO FULL TRANSCRIPT</a></p>
April 29, 2026
<p>In this JCO PO Article Insights episode, host Carolyn Lineen summarizes the article, "<a href= "https://ascopubs.org/doi/10.1200/PO-25-00725" target="_blank" rel= "noopener">Prognostic Significance of Blood-Based Multicancer Detection in Circulating Tumor DNA: Five-Year Outcomes Analysis</a>" bySwanton et al.</p> <p><a href= "https://ascopubs.org/do/jco-po-article-insights-circulating-cancer-genome-atlas-study-5-year-outcomes" target="_blank" rel="noopener"><strong>LINK TO FULL TRANSCRIPT</strong></a></p>
Guests from recent episodes — sign up to see every guest that has ever appeared on this show.
Dr Rafeh Naqash
Guest
Dr Miles C Andrews
Guest
Discover related shows you might enjoy
American Society of Clinical Oncology (ASCO)
American Society of Clinical Oncology (ASCO)
NEJM Group
American Society of Clinical Oncology (ASCO)
STAT
OncLive® On Air
NEJM Group
Hank Smith & John Bytheway
JAMA Network
Peter Attia, MD
BBC World Service
The Curbsiders Internal Medicine Podcast
JAMA Network
Oncology Brothers
Pushkin Industries
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
JCO Precision Oncology Conversations podcasts features discussions with leading authors of JCO Precision Oncology articles, hosted by Dr. Abdul Rafeh Naqash. Join our experts in engaging conversations as they examine groundbreaking research in the world of precision oncology and learn how these advancements are redefining treatment protocols.
The year's fellows summarize the top JCO Precision Oncology articles in the series, JCO PO Article Insights.
This podcast updates weekly.
This podcast is available on 8 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
Information about guest appearances is not available.
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.